NYSE: OSCR

Oscar Health (OSCR) Stock Analysis & Forecast

Nov 13 close

$31.05−0.89 (−2.8%)

Gekko Brief

AI summaryNov 9 close

Oscar Health moved this week on third-quarter results, as the company reported a profit of $0.49 per share against an expected loss of $0.14, beating estimates, with revenue projected to surge 58.1% to $4.7 billion for the quarter. The company raised its full-year 2026 operating earnings outlook for the third time, citing higher membership, premium rates, and a $250 million benefit from updated risk-adjustment data. Despite the beat and raised guidance, shares reacted with an 11.8% average absolute move historically, and the last reaction to earnings was -12.9%.

The stock closed at $32.14, up 4.9%, sitting above both its 50-day average of $31.87 and 200-day average of $24.09, with the 50-day above the 200-day. The GekkoIndex reads 58.2, placing OSCR in the Neutral zone, down 2.3 over five days. Price sits 4.5% below Gekko Fair Value of $33.66. One-year return stands at 94.1%, while the one-month return is -3.7%.

The next earnings date falls on 9 February 2027, outside a typical 20-trading-day hold. Over the last 30 days, 2 unusual options signals appeared, with call premium of $662,732 against put premium of $33,579. Analyst consensus across 9 firms shows 3 buy, 5 hold, and 1 sell ratings, with a consensus target of $36.40. Seasonality over the next 20 trading days has averaged -5.6% across 5 years, rising in 2 of them, a pattern worth noting alongside the current setup.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Oscar Health price vs fair value

$34.00$31.05Nov ’25May ’26Nov ’26
Close $31.05200-day averageGekko Fair Value $34.00

Oscar Health quick facts

Market cap
$8.05B
P/E ratio
14.2
Forward P/E
588.2
EPS, TTM
$2.25
Revenue, TTM
$17.47B
Profit margin
4.9%
Dividend yield
—
Beta
2.49
Volume
4.61M avg 5.34M
1-year return
+105.6%
Typical daily move
±7.1%
Typical 20-day move
±15.8%
50-day average
$32.00
200-day average
$24.43
Next earnings
Feb 9 before open
Shares outstanding
275.5M
52-week range
$10.69$38.50

Oscar Health swing-trade checklist

Oscar Health scores 4 supportive, 2 mixed and 0 headwinds across the 6 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

4 supportive2 mixed0 headwinds

  • Trendmixed

    Averages disagree

    Close $31.05 sits between the 50-day ($32.00) and 200-day ($24.43) averages, or the averages disagree.

    See the chart
  • GekkoIndexsupportive

    60.3, Accumulation

    Reading 60.3 is in the Accumulation zone.

    See the GekkoIndex
  • Fair valuesupportive

    8.7% below

    Price is 8.7% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneysupportive

    Leans bullish

    Last 30 days: 1 unusual options signal.

    See smart money
  • Earnings risksupportive

    Reports in 86 days

    Next report Feb 9, 2027, 86 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitymixed

    −2.3% on average

    From this point in the calendar, the next 20 trading days averaged −2.3% over 5 years, rising in 3 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Oscar Health stock chart and price history

Oscar Health closed at $31.05 on Nov 13, 2026, +105.6% over the past year, inside a 52-week range of $10.69 to $38.50.

Close50-day average200-day averageVolume
Oscar Health share price, past year, with 50-day and 200-day moving averages and volume$10$15$20$25$35DecJan 2026FebMarAprMayJunJulAugSepOctNov31.05

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
−7.2%
3 months
−1.6%
6 months
+33.1%
1 year
+105.6%
The full OSCR chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open OSCR in Gekko

Follow Oscar Health through every session

Put OSCR on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track OSCR in GekkoFree for 7 days. No credit card required.

About Oscar Health

Oscar Health provides health insurance to people across the United States, with plans built for individuals and families, small businesses, and those eligible for Medicare Advantage. The company has become known for pairing coverage with its own technology platform, called +Oscar, which connects doctors, insurers, and the members or patients they serve.

Beyond selling insurance plans directly to consumers and businesses, Oscar Health also offers reinsurance arrangements as part of its business. The +Oscar platform itself is positioned as a tool that other healthcare providers and payers can use to manage engagement with their own patient and member bases.

The company was founded in 2012 under the name Mulberry Health Inc. before adopting its current name, Oscar Health, Inc., in January 2021. It is headquartered in New York, New York, and its shares are listed on the NYSE under the ticker OSCR.

Listed
NYSE
Sector
Health services
Industry
Managed health care
Website
hioscar.com

Oscar Health GekkoIndex: the smart money zone

Oscar Health’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 60.3, in the Accumulation zone, up 1.5 points over five sessions.

010060.3Accumulation

Up 1.5 points over five sessions, from the Neutral zone.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying22+9.6%+15.9%+16.9%+36.1%
Accumulation (current zone)241+1.4%+3.0%+7.2%+17.9%
Neutral357+0.6%+1.6%+2.8%+4.4%
Distribution77+1.4%+1.1%+0.1%+5.5%
Selling5Too few readings yet

Average OSCR share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.

Accumulation zone: Institutional interest building. About the five zones →

See every daily GekkoIndex reading plotted over the OSCR price, zone by zone.Track OSCR in Gekko

Is Oscar Health stock overvalued? Gekko Fair Value

Oscar Health trades 8.7% below Gekko Fair Value of $34.00, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Oscar Health shares are worth, recalculated every trading day.

$34.00

Gekko Fair Value, Nov 14, 2026

8.7% Undervalued

At the end of Aug 2026 the price was 1.3% below the estimate.

Gekko Fair ValueShare price, month end
$34$31Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open OSCR in Gekko

Oscar Health insider and Congress trading

No open-market insider purchases were filed for Oscar Health, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for OSCR in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every OSCR insider filing, plotted on the chart in Gekko.Open OSCR in Gekko

Congress trades last 90 days

No trades in OSCR were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for OSCR, plotted on the chart in Gekko.Open OSCR in Gekko

Buybacks

Oscar Health has been buying back its own shares.

Bought back, year ended Dec 31, 2019
$2.99M
As a share of market cap
0.04%

From company filings.

Unusual options activity last 30 days

1signal, 90% of the flagged premium in calls.

Latest: Bullish flow on Nov 5, $344K in unusual premium.

Hedge funds and billionaires quarter ended Jun 30

1of the funds Gekko tracks holds OSCR.

0added1opened0trimmed1sold out
Every signal with its contract, strike and premium, and which funds are on each side.Unlock in Gekko

Oscar Health earnings: next date and track record

Oscar Health reports on Feb 9, 2027, before the open (86 days away), and beat the EPS estimate in 6 of its last 8 reports.

6 of 8reports beat the EPS estimate
±11.8%average move across the report
5 of 8reports followed by a gain

Share-price move across each report

−6.0%Feb ’25+30.5%May ’25+9.7%Aug ’25+4.1%Nov ’25+7.4%Feb ’26+16.3%May ’26−7.3%Aug ’26−12.9%Nov ’26

Last earnings call, Nov 5, 2026 AI summary

What they said
Oscar Health reported record profitability for the first 9 months of 2026, with earnings from operations of $1.3 billion and net income of $1.2 billion. Membership reached 2.7 million, up 27% year-over-year. The company is expanding its footprint to 713 counties across 21 states with a total addressable market of ~10 million consumers. New products include RetireEase for early retirees and an Allstate Health Solutions partnership. The Lucie platform is on track to sell ~800,000 new policies in 2027.
Guidance
Oscar raised 2026 earnings from operations guidance, achieving several 2024 Investor Day commitments one year ahead of plan. Management expects sustainable financial performance in 2027 and beyond, with Lucie projected to sell approximately 800,000 new policies in 2027.
ReportedEPSSurpriseRevenueSurpriseMove
Nov 5, 2026$0.49
est −$0.14
+440.7%$5.14B
est $4.69B
+9.5%−12.9%
Aug 6, 2026$1.10
est $0.43
+155.8%$4.79B
est $4.73B
+1.3%−7.3%
May 6, 2026$2.07
est $1.10
+88.2%$4.58B
est $4.90B
−6.5%+16.3%
Feb 10, 2026−$1.24
est −$0.92
−34.6%$2.75B
est $3.12B
−12.1%+7.4%
Nov 6, 2025−$0.53
est −$0.55
+3.6%$2.99B
est $3.05B
−2.2%+4.1%
Aug 6, 2025−$0.89
est −$0.90
+1.1%$2.86B
est $3.07B
−6.8%+9.7%
May 7, 2025$0.92
est $0.83
+10.8%$3.05B
est $2.78B
+9.6%+30.5%
Feb 4, 2025−$0.62
est −$0.58
−6.9%$2.39B
est $2.83B
−15.3%−6.0%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Oscar Health stock forecast and analyst price targets

Analysts’ average 12-month price target for Oscar Health is $37.00, +19.2% from the last close, from 9 firms rating the stock in the last 90 days.

$37.00consensus 12-month target, +19.2% from the last close
Low $27High $49
Buy3
Hold5
Sell1

Each firm’s latest rating in the last 90 days: 9 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 6UBSHold, maintained$38+22.4%
Nov 6Piper SandlerBuy, reiterated$45+44.9%
Nov 6BarclaysBuy, maintained$49+57.8%
Oct 12UBSHold, reiterated$36+15.9%
Sep 23Piper SandlerBuy, maintained$48+54.6%
+7.2%average 20-day move after past Accumulation readings
−2.3%average move over the next 20 trading days in the last 5 years
±7.1%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Oscar Health seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Oscar Health averaged −2.3% across the last 5 years, rising in 3 of them.

Next 20 trading days, by year

−32.7%2021−10.6%2022+14.3%2023−11.5%2024+16.3%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days+4.8%3 of 5
Next 10 trading days+7.1%3 of 5
Next 15 trading days+6.8%3 of 5
Next 20 trading days−2.3%3 of 5
Next 30 trading days−5.0%3 of 5

For scale, OSCR’s typical 20-trading-day move in either direction is about 15.8%.

Oscar Health market cap and key statistics

Oscar Health’s market cap is $8.05B, with a P/E ratio of 14.2 and revenue of $17.47B over the last twelve months.

Valuation

Market cap
$8.05B
P/E ratio
14.2
Forward P/E
588.2
EPS, TTM
$2.25
Gekko Fair Value
$34.00

Trading

Volume
4.61M
Avg volume, 20 days
5.34M
52-week high
$38.50
52-week low
$10.69
Shares outstanding
275.5M

Financials

Revenue, TTM
$17.47B
Profit margin
4.9%
Return on equity
52.6%
Quarterly earnings growth, YoY
+125.6%

Risk and income

Beta
2.49
Typical daily move
±7.1%
Typical 20-day move
±15.8%

Oscar Health stock news this week

4 headlines about Oscar Health from the past week, newest first, each linking to the publisher.

Oscar Health peers

Oscar Health’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
UNHUnitedHealth−0.1%Neutral9.7% above
ELVElevance Health−0.6%Neutral31.3% below
CICigna−0.6%Neutral35.4% below
HUMHumana+1.0%Neutral16.1% below
CNCCentene+0.6%Neutral19.3% below
MOHMolina Healthcare−0.8%Neutral38.6% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Managed health care

Oscar Health stock FAQ

What is Oscar Health’s market cap?

Oscar Health’s market cap is $8.05B at the Nov 13, 2026 close of $31.05, with 275.5M shares outstanding. The shares trade on a P/E ratio of 14.2.

What is the Oscar Health stock forecast?

The consensus analyst 12-month price target for Oscar Health is $37.00, +19.2% from the last close. Of the 9 firms that rated the stock in the last 90 days, 3 rate it a buy, 5 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.

Is Oscar Health stock overvalued or undervalued?

On Gekko’s estimate Oscar Health is undervalued: the Nov 13, 2026 close of $31.05 is 8.7% below Gekko Fair Value of $34.00. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Oscar Health report earnings next?

Oscar Health is expected to report on Feb 9, 2027, before the market opens (86 days away). Analysts expect earnings of −$1.08 per share on revenue of $4.48B. Oscar Health beat the earnings estimate in 6 of its last 8 reports, moving 11.8% on average across the report.

What is Oscar Health’s 52-week high and low?

Oscar Health’s 52-week high is $38.50 and its 52-week low is $10.69; it closed at $31.05 on Nov 13, 2026, +105.6% over the past year.

Is Oscar Health stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 6 items with data read as supportive (gekkoindex, fair value, smart money and earnings risk), 2 as mixed (trend and seasonality). The checklist is a description of current data, not a recommendation.

Is there unusual options activity in Oscar Health?

Gekko flagged 1 unusual options signal in Oscar Health over the last 30 days, with $311K of flagged premium in calls and $34K in puts. The latest, bullish flow, was on Nov 5, 2026 with $344K in unusual premium. The signal-by-signal table is in Gekko.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Oscar Health the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.